Htran, thanks. We all invest in the prospect of XPD to do well and prosper. They seems to have an issue with governance and the turn over of Australian Directors.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025